EstroPlus Supplement (Perrigo) – contamination risk (2013)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
EstroPlus Maximum Strength Menopause Support Dietary Supplement in 28 count and 56 count blister strips under the following labels - CareOne Maximum Strength Multi Symptom Menopause Formula, 28 Caplets/Dietary Supplement; Meijer Maximum Strength Estroplus, Dietary Supplement, 28 Caplets; TopCare Maximum Strength Estroplus Dietary Supplement, 28 Caplets; Sunmark Estroplus Extra Strength, Dietary Supplement, 56 Caplets; Health Mart Pharmacy Extra Strength Estroplus, 56 Caplets Dietary Supplement;
Brand
Perrigo of SC
Lot Codes / Batch Numbers
3FN0981 (Exp 04/15), 3FN1338 (Exp 04/15), 3FN1116 (Exp 04/15), 3EN1050 (Exp 04/15), 3JN1230 (Exp 04/15), 3KN1691 (Exp 05/15), 3KN1207 (Exp. 05/15), 3JN1013 (05/15), 3JN1077 (Exp 05/15), 3HN1293 (Exp 05/15), 1KN1496 (Exp 05/14), 1JN1234 (Exp 05/14), 1KN1775 (Exp. 05/14), 1LN1254 (Exp 05/14), 1LN1867 (Exp 05/14), 1MN1647 (Exp 05/14), 2AN1562 (Exp 10/14), 2AN1595 (Exp 10/14), 2BN2120 (Exp 01/15), 2DN1514 (Exp 01/15), 2DN1515 (Exp 10/14), 2DN1608 (Exp 05/14), 2DN1997 (Exp 01/15), 2EN2099 (Exp. 01/15), 2FN1524 (Exp 03/15), 2FN1923 (Exp 03/15), 2FN1939 (Exp 01/15), 2GN1806 (Exp 03/15), 2HN1412 (Exp 03/15), 2HN1496 (Exp 03/15), 2JN1383 (Exp 03/15), 2MN1156 (Exp 03/15), 3AN1835 (Exp 03/15), 3BN1683 (Exp 03/15), 3DN1482 (Exp 03/15), 3FN1132 (Exp 03/15)
Products Sold
3FN0981 (Exp 04/15), 3FN1338 (Exp 04/15), 3FN1116 (Exp 04/15), 3EN1050 (Exp 04/15), 3JN1230 (Exp 04/15), 3KN1691 (Exp 05/15), 3KN1207 (Exp. 05/15), 3JN1013 (05/15), 3JN1077 (Exp 05/15), 3HN1293 (Exp 05/15), 1KN1496 (Exp 05/14), 1JN1234 (Exp 05/14), 1KN1775 (Exp. 05/14), 1LN1254 (Exp 05/14), 1LN1867 (Exp 05/14), 1MN1647 (Exp 05/14), 2AN1562 (Exp 10/14), 2AN1595 (Exp 10/14), 2BN2120 (Exp 01/15), 2DN1514 (Exp 01/15), 2DN1515 (Exp 10/14), 2DN1608 (Exp 05/14), 2DN1997 (Exp 01/15), 2EN2099 (Exp. 01/15), 2FN1524 (Exp 03/15), 2FN1923 (Exp 03/15), 2FN1939 (Exp 01/15), 2GN1806 (Exp 03/15), 2HN1412 (Exp 03/15), 2HN1496 (Exp 03/15), 2JN1383 (Exp 03/15), 2MN1156 (Exp 03/15), 3AN1835 (Exp 03/15), 3BN1683 (Exp 03/15), 3DN1482 (Exp 03/15), 3FN1132 (Exp 03/15)
Perrigo of SC is recalling EstroPlus Maximum Strength Menopause Support Dietary Supplement in 28 count and 56 count blister str due to Potential presence of Chloramphenicol contamination. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Potential presence of Chloramphenicol contamination
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
FL, IL, MI, MN, OR, PA, TX
Page updated: Jan 6, 2026